Renaissance Technologies (RenTech)'s PVLA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 22,530 shares of Palvella Therapeutics, Inc. (PVLA) worth $2.36 M, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 5 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in PVLA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 51,600 shares. Largest reduction occurred in Q4 2025, reducing 67,167 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Palvella Therapeutics (PVLA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Palvella Therapeutics (PVLA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -67,167 | Reduce 74.88% | 22,530 | $104.67 |
| Q3 2025 | +22,839 | Add 34.16% | 89,697 | $62.69 |
| Q2 2025 | +51,600 | Add 338.18% | 66,858 | $22.54 |
| Q1 2025 | -6,113 | Reduce 28.60% | 15,258 | $27.99 |
| Q4 2024 | +21,371 | New Buy | 21,371 | $12.00 |
Renaissance Technologies (RenTech)'s Palvella Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Palvella Therapeutics, Inc. (PVLA) in Q4 2024, acquiring 21,371 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Palvella Therapeutics, Inc. (PVLA) for 5 quarters since Q4 2024.
Renaissance Technologies (RenTech)'s largest addition to Palvella Therapeutics, Inc. (PVLA) was in Q2 2025, adding 66,858 shares worth $1.51 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 22,530 shares of Palvella Therapeutics, Inc. (PVLA), valued at approximately $2.36 M.
As of the Q4 2025 filing, Palvella Therapeutics, Inc. (PVLA) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Palvella Therapeutics, Inc. (PVLA) was 89,697 shares, as reported at the end of Q3 2025.